Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure - PubMed (original) (raw)
. 1991 Apr 25;266(12):7329-32.
Affiliations
- PMID: 2019568
Free article
Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure
S Horiuchi et al. J Biol Chem. 1991.
Free article
Abstract
Reaction of protein amino groups with glucose (the Maillard reaction) leads from early stage products such as Schiff base and Amadori products to advanced glycation end products (AGE), structures implicated in diabetic complications and the aging process. We have prepared the polyclonal anti-AGE antibody and the monoclonal anti-AGE antibody against AGE-bovine serum albumin and made an immunochemical approach to characterize AGE structures. Both polyclonal and monoclonal antibodies reacted with AGE-proteins such as AGE-bovine serum albumin, AGE-human serum albumin, and AGE-hemoglobin but not with unmodified counterparts. Treatments of these AGE-proteins with borohydride had no effect on the immunoreactivity. Moreover, fructosyl-epsilon-caproic acid, a synthetic Amadori compound, did not serve as an antigen, indicating that these antibodies were specific for AGE products but not for early stage products of the Maillard reaction. In addition, these antibodies were also able to recognize AGE products prepared either from alpha-tosyl-1-lysine, alpha-tosyl-1-lysine methyl ester, monoaminocarboxylic acid such as epsilon-aminocaproic acid, gamma-amino-n-butyric acid, and beta-alanine. Thus, these results strongly suggest the presence of a common structure in AGE preparations, regardless of whether AGE products are generated from proteins, amino acids, or monoaminocarboxylic acids.
Similar articles
- N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.
Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, Ueda S, Horiuchi S. Ikeda K, et al. Biochemistry. 1996 Jun 18;35(24):8075-83. doi: 10.1021/bi9530550. Biochemistry. 1996. PMID: 8672512 - Production and characterization of antibodies to advanced glycation products on proteins.
Nakayama H, Taneda S, Kuwajima S, Aoki S, Kuroda Y, Misawa K, Nakagawa S. Nakayama H, et al. Biochem Biophys Res Commun. 1989 Jul 31;162(2):740-5. doi: 10.1016/0006-291x(89)92372-3. Biochem Biophys Res Commun. 1989. PMID: 2474294 - Conversion of Amadori products of the Maillard reaction to N(epsilon)-(carboxymethyl)lysine by short-term heating: possible detection of artifacts by immunohistochemistry.
Miki Hayashi C, Nagai R, Miyazaki K, Hayase F, Araki T, Ono T, Horiuchi S. Miki Hayashi C, et al. Lab Invest. 2002 Jun;82(6):795-808. doi: 10.1097/01.lab.0000018826.59648.07. Lab Invest. 2002. PMID: 12065691 - The Maillard reaction and its consequences for a living body.
Sztanke K, Pasternak K. Sztanke K, et al. Ann Univ Mariae Curie Sklodowska Med. 2003;58(2):159-62. Ann Univ Mariae Curie Sklodowska Med. 2003. PMID: 15323185 Review. - Advanced glycation endproducts in food and their effects on health.
Poulsen MW, Hedegaard RV, Andersen JM, de Courten B, Bügel S, Nielsen J, Skibsted LH, Dragsted LO. Poulsen MW, et al. Food Chem Toxicol. 2013 Oct;60:10-37. doi: 10.1016/j.fct.2013.06.052. Epub 2013 Jul 16. Food Chem Toxicol. 2013. PMID: 23867544 Review.
Cited by
- Advanced Glycation End Products in the Skin: Molecular Mechanisms, Methods of Measurement, and Inhibitory Pathways.
Chen CY, Zhang JQ, Li L, Guo MM, He YF, Dong YM, Meng H, Yi F. Chen CY, et al. Front Med (Lausanne). 2022 May 11;9:837222. doi: 10.3389/fmed.2022.837222. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35646963 Free PMC article. Review. - Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.
Hoang A, Murphy AJ, Coughlan MT, Thomas MC, Forbes JM, O'Brien R, Cooper ME, Chin-Dusting JP, Sviridov D. Hoang A, et al. Diabetologia. 2007 Aug;50(8):1770-9. doi: 10.1007/s00125-007-0718-9. Epub 2007 Jun 20. Diabetologia. 2007. PMID: 17579831 - Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells.
Wei Y, Chen L, Chen J, Ge L, He RQ. Wei Y, et al. BMC Cell Biol. 2009 Feb 13;10:10. doi: 10.1186/1471-2121-10-10. BMC Cell Biol. 2009. PMID: 19216769 Free PMC article. - beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T. Miyata T, et al. J Clin Invest. 1993 Sep;92(3):1243-52. doi: 10.1172/JCI116696. J Clin Invest. 1993. PMID: 8376584 Free PMC article. - Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.
Kume S, Takeya M, Mori T, Araki N, Suzuki H, Horiuchi S, Kodama T, Miyauchi Y, Takahashi K. Kume S, et al. Am J Pathol. 1995 Sep;147(3):654-67. Am J Pathol. 1995. PMID: 7545874 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources